Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

Description

To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals

Conditions

Prediabetes / Type 2 Diabetes

Study Overview

Study Details

Study overview

To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals

Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

Condition
Prediabetes / Type 2 Diabetes
Intervention / Treatment

-

Contacts and Locations

Little Rock

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Males and females ages 50-70 years.
  • 2. Capable of providing informed consent.
  • 3. COVID-19 negative and/or asymptomatic.
  • 4. Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 7-day study meal period on two occasions.
  • 5. HbA1c: 5.7-6.4% or 6.5% to 7.5%
  • 1. Subject who does not/will not eat dairy protein sources.
  • 2. Subjects taking exogenous insulin injections or GLP /GIP injections or other appetite suppressants.
  • 3. Unwilling to keep a detailed 7 day food journal on two occasions
  • 4. Unwilling to wear a CGM for 7 days on two occasions and share the data with the research team.
  • 5. Lactose intolerance.
  • 6. Hemoglobin \<10g/dL at screening.
  • 7. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
  • 8. History of gastrointestinal bypass/reduction surgery.
  • 9. Pregnant or lactating individuals.
  • 10. History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)
  • 11. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
  • 12. Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.).
  • 13. Unwilling to avoid using protein or amino-acid supplements during participation.
  • 14. Unwilling to fast overnight.
  • 15. Any medical condition or medication that the PI or clinical study staff finds contradictory to this study.

Ages Eligible for Study

50 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Arkansas,

Study Record Dates

2026-11-01